From Real-World Patient Data to Individualized Treatment Effects Using Machine Learning: Current and Future Methods
Ioana Bica1,2, Ahmed M Alaa3, Craig Lambert4
1University of Oxford, Oxford, UK.
Clinical Pharmacology and Therapeutics
|May 26, 2020
Summary
Leveraging electronic health records (EHRs) with machine learning can estimate individualized treatment effects. Combining EHR data with randomized control trials (RCTs) and pharmacological models offers future directions for personalized medicine.
Area of Science:
- Biomedical Informatics
- Machine Learning
- Causal Inference
Background:
- Randomized control trials (RCTs) establish drug efficacy but lack patient heterogeneity data.
- Electronic health records (EHRs) capture diverse patient data and treatment responses.
- Individualized treatment decisions require evidence of patient-specific benefits.
Purpose of the Study:
- To explore opportunities and challenges of using observational data for machine learning-based individualized treatment effect estimation.
- To describe state-of-the-art machine learning methods for causal inference in treatment effect estimation.
- To highlight future research for leveraging EHRs and machine learning in personalized treatment recommendations.
Main Methods:
- Utilizing machine learning for causal inference on observational data (EHRs).
- Describing cross-sectional and longitudinal modeling approaches for treatment effect estimation.
- Integrating experimental data (RCTs) and quantitative pharmacology models.
Main Results:
- Machine learning methods can estimate individualized treatment effects from EHR data.
- Observational data offers insights into heterogeneous patient responses to treatments.
- Future research directions focus on validating and improving ML models with diverse data sources.
Conclusions:
- EHRs and machine learning hold significant potential for personalized treatment recommendations.
- Collaboration across disciplines is crucial to integrate RCTs, disease models, and EHR-based ML.
- Combining diverse data sources will optimize individualized treatment strategies.
Related Concept Videos
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Issues And Trends In Healthcare Delivery System
6.1K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.1K
Dosage Regimen: Individualization
111
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
111
Analysis of Population Pharmacokinetic Data
602
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
602
Therapeutic Drug Monitoring: Affecting Factors
126
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
126
Therapeutic Drug Monitoring: Overview and Classification
196
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
196


